-
Talk to Us: info@nidccglobal.org
-
Location: Washington, DC | Abuja, Nigeria
Language:
Everyday Economic News
Summit Therapeutics (NASDAQ: SMMT) pulls planned stock sale amid markets
Summit Therapeutics Inc. announced it has withdrawn its previously planned underwritten public offering of securities, effective June 10, 2026, citing unfavorable market conditions. As a result, no securities will be sold under this proposed transaction. This disclosure is made under Regulation FD and is not considered a "filed" report for liability purposes under Section 18 of the Exchange Act.
[EFFECT] BullFrog AI Holdings, Inc. SEC Filing
This article reports on an SEC filing by BullFrog AI Holdings, Inc. (BFRG), specifically an "EFFECT" filing, indicating the effectiveness of a registration statement. The filing, dated June 10, 2026, pertains to a Form S-1 for the company. The article also provides recent news and SEC filings related to BullFrog AI, along with stock data and company information.
PICS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PicS N.V. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PicS N.V. on behalf of investors who purchased Class A common stock during or traceable to the company's January 30, 2026 IPO. The lawsuit alleges that PicS N.V. and its executives made false and misleading statements in the IPO offering documents, particularly regarding credit evaluation procedures and heightened default risks. Investors who suffered substantial losses have until August 4, 2026, to seek appointment as lead plaintiff in the case.
PICS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PicS N.V. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PicS N.V. on behalf of investors who purchased Class A common stock in or traceable to the company's January 30, 2026 IPO. The lawsuit alleges that PicS N.V. made false and/or misleading statements and omitted material information in its IPO offering documents regarding its credit evaluation procedures, reclassification of exposures, and credit quality, leading to a significant drop in stock price. Investors who suffered substantial losses have until August 4, 2026, to seek appointment as lead plaintiff in the lawsuit.